|53.56||+0.01 / +0.02%|
Data as of Sep 29
|53.74||+0.18 / +0.34%|
The 22 analysts offering 12-month price forecasts for Teva Pharmaceutical Industries Ltd have a median target of 60.00, with a high estimate of 70.00 and a low estimate of 54.00. The median estimate represents a +12.02% increase from the last price of 53.56.
The current consensus among 26 polled investment analysts is to Buy stock in Teva Pharmaceutical Industries Ltd. This rating has held steady since September, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.